English Information

Aufzählung

Das Forschungsdesign

Aufzählung

Hintergrundinformationen

Aufzählung

Beteiligte Forschungsinstitute

Aufzählung

Ergebnisse

Aufzählung

Publikationen

Aufzählung

Presse

Aufzählung

Veranstaltungen

Aufzählung

Projekte vor Ort

Aufzählung

Internationale Forschung

Aufzählung

Chronologie

Aufzählung

Häufig gestellte Fragen

Aufzählung

Kontakt

In the German model project, severely dependent drug addicted patients
receive injectable heroin as medication on a trial basis within the framework of a
scientific study. A parallel control group receives the substitution drug
methadone. Both groups receive regular medical care and concomitant
psychosocial treatment. Target group are those drug dependent patients, who
were not successfully treated by any other therapy and/or whose course of
methadone treatment has not been satisfactory so far.

The model project is a joint venture of the Federal Health Ministry, the
federal states of Hamburg, Hessen, Niedersachsen and Nordrhein-Westfalen and
the cities of Bonn, Frankfurt/Main, Hanover, Karlsruhe, Cologne and Munich,
and it is accompanied by the professional organisation of German doctors
(Bundesärztekammer). Professor Michael Krausz, Centre of Interdisciplinary
Addiction Research (ZIS) at the University of Hamburg, is in charge of the
study's scientific design and implementation. Starting October 2003, Prof. Dr. Dieter Naber is director of the clinical trial (Leiter der klinischen Prüfung, LKP). Clinical project director is Prof. Dr. Christian Haasen (both ZIS).

  • An English description of the study design is available for download here.
  • A summary of study reports of the first and second study phase is available here
  • Clinical Study Report of the first study phase is available here.
  • Clinical Study Report of the second study phase is available here.
[Main page in German]

          

    Updated: 15.05.07